JFS Wealth Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $287K | Sell |
2,272
-49
| -2% | -$6.46K | 0.01% | 302 |
|
|
2026
Q1 | $323K | Buy |
2,321
+12
| +0.5% | +$1.68K | 0.02% | 269 |
|
|
2025
Q4 | $283K | Buy |
2,309
+273
| +13% | +$33.2K | 0.02% | 280 |
|
|
2025
Q3 | $226K | Hold |
2,036
| – | – | 0.01% | 312 |
|
|
2025
Q2 | $226K | Sell |
2,036
-5
| -0.2% | -$532 | 0.01% | 285 |
|
|
2025
Q1 | $229K | Buy |
2,041
+6
| +0.3% | +$619 | 0.02% | 284 |
|
|
2024
Q4 | $188K | Buy |
2,035
+1
| +0% | +$90 | 0.01% | 296 |
|
|
2024
Q3 | $171K | Buy |
2,034
+1,631
| +405% | +$124K | 0.01% | 303 |
|
|
2024
Q2 | $27.6K | Sell |
403
-9
| -2% | -$601 | ﹤0.01% | 530 |
|
|
2024
Q1 | $30.2K | Sell |
412
-48
| -10% | -$3.69K | ﹤0.01% | 532 |
|
|
2023
Q4 | $37.3K | Buy |
460
+59
| +15% | +$4.59K | ﹤0.01% | 459 |
|
|
2023
Q3 | $30.1K | Sell |
401
-3
| -0.7% | -$231 | ﹤0.01% | 454 |
|
|
2023
Q2 | $31.1K | Sell |
404
-10
| -2% | -$798 | ﹤0.01% | 443 |
|
|
2023
Q1 | $34.4K | Sell |
414
-13
| -3% | -$1.08K | ﹤0.01% | 425 |
|
|
2022
Q4 | $36.7K | Buy |
427
+27
| +7% | +$2.14K | ﹤0.01% | 410 |
|
|
2022
Q3 | $25K | Buy |
400
+162
| +68% | +$10.2K | ﹤0.01% | 518 |
|
|
2022
Q2 | $15K | Buy |
238
+52
| +28% | +$3.22K | ﹤0.01% | 648 |
|
|
2022
Q1 | $11K | Buy |
186
+92
| +98% | +$5.88K | ﹤0.01% | 760 |
|
|
2021
Q4 | $7K | Buy |
94
+74
| +370% | +$5.1K | ﹤0.01% | 737 |
|
|
2021
Q3 | $1K | Hold |
20
| – | – | ﹤0.01% | 807 |
|
|
2021
Q2 | $1K | Hold |
20
| – | – | ﹤0.01% | 576 |
|
|
2021
Q1 | $1K | Buy |
+20
| New | +$1.29K | ﹤0.01% | 567 |
|
|
2016
Q4 | – | Sell |
-34
| Closed | -$3K | – | 459 |
|
|
2016
Q3 | $3K | Hold |
34
| – | – | ﹤0.01% | 443 |
|
|
2016
Q2 | $3K | Hold |
34
| – | – | ﹤0.01% | 458 |
|
|
2016
Q1 | $3K | Hold |
34
| – | – | ﹤0.01% | 483 |
|
|
2015
Q4 | $3K | Hold |
34
| – | – | ﹤0.01% | 484 |
|
|
2015
Q3 | $3K | Sell |
34
-56
| -62% | -$6.22K | ﹤0.01% | 417 |
|
|
2015
Q2 | $11K | Sell |
90
-1
| -1% | -$109 | 0.01% | 352 |
|
|
2015
Q1 | $9K | Sell |
91
-70
| -43% | -$7.11K | ﹤0.01% | 372 |
|
|
2014
Q4 | $15K | Buy |
161
+90
| +127% | +$9.31K | ﹤0.01% | 320 |
|
|
2014
Q3 | $8K | Sell |
71
-170
| -71% | -$16.6K | ﹤0.01% | 352 |
|
|
2014
Q2 | $20K | Buy |
+241
| New | +$18.8K | ﹤0.01% | 260 |
|
Other funds holding GILD
JFS Wealth Advisors's GILD Position: Q2 2026 in Review
JFS Wealth Advisors reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $6.46K and leaving 2,272 shares worth $287K. The position accounts for 0.01% of the portfolio, ranked #302.
JFS Wealth Advisors first reported a position in GILD in Q2 2014 and has held it in 32 quarters since. The position peaked at $323K in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- JFS Wealth Advisors held 2,272 shares of Gilead Sciences worth $287K as of Q2 2026.
- JFS Wealth Advisors sold 49 Gilead Sciences shares in Q2 2026, an estimated $6.46K.
- Gilead Sciences made up 0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #302 holding.
- JFS Wealth Advisors first reported a position in Gilead Sciences in Q2 2014 and has held it in 32 quarters since.
- JFS Wealth Advisors's Gilead Sciences position peaked at $323K in Q1 2026.
- 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.